NuPathe’s Battery-Powered Sumatriptan Patch to Treat Nausea Gets FDA Nod

by Kathy Jones on  January 19, 2013 at 7:57 PM Medical Gadgets
RSS Email Print This Page Comment
Font : A-A+

The US Food and Drug Administration has approved NuPathe's battery-powered sumatriptan patch to treat nausea and headaches caused by migraines in adults.
 NuPathe’s Battery-Powered Sumatriptan Patch to Treat Nausea Gets FDA Nod
NuPathe’s Battery-Powered Sumatriptan Patch to Treat Nausea Gets FDA Nod

The single-use patch, known as Zecuity, will provide relief from symptoms of migraines with or without aura. When the user starts to suffer from migraine, the patch can be applied to the upper arm or thigh and a dosage of 6.5 mg of sumatriptan can be released over a period of four hours by pressing a button.

This is NuPathe's second application for transdermal sumatriptan patch after the FDA had rejected a similar product, known as Zelrix, back in August 2011, citing concerns over manufacturing and patient's safety.

NuPathe's CEO Armando Anido said that the company expects to bring the product in the market by the end of this year. "We anticipate the product will be available for sale in the fourth quarter of this year. We're right now in conversations with a number of people for partnership in the United States", Anido said.

Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Vertigo Nausea and Vomiting 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive